|
 |
 |
|
Details For Selected Brain Tumor Treatment
|
 |
|
|
| Sponsored By |
|
| Please Click On The Above Banner For More Details |
|
|
 |
 |
 |
 |
 |
 |
Treatment Name: |
 |
A Phase I/II Trial of ZD6474 for Patients With Recurrent High-Grade and Progressive Low-Grade Gliomas
|
 |
 |
 |
 |
Phase: |
 |
Phase 2 |
 |
 |
 |
 |
 |
 |
Treatment ID#: |
 |
1917 |
 |
 |
 |
 |
Age Group: |
 |
Adults Only |
 |
 |
 |
 |
 |
 |
Min Karnofsky Score: |
 |
Not Specified |
 |
 |
 |
 |
Conditions: |
 |
Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed |
 |
 |
 |
 |
 |
 |
Last Updated: |
 |
04/22/2009 |
 |
 |
 |
 |
Tumor Types: |
 |
Anaplastic Astrocytoma Brainstem Glioma Glioblastoma Multiforme Low Grade Glioma Medulloblastoma Oligodendroglioma High Grade Oligodendroglioma Low Grade |
 |
 |
 |
 |
 |
 |
 |
Comments: |
 |
|
 |
 |
 |
 |
 |
 |
Treatment Type: |
 |
Chemotherapy Less-Toxics |
 |
 |
 |
 |
Contact: |
 |
NCI Cheryl Royce, CRNP, Clinical Director National Cancer Institute Neuro-oncology Branch 9030 Old Georgetown Road Bethesda, MD 20892 USA Phone: 866-251-9686 Fax: E-mail: roycec@mail.nih.gov Website: home.ccr.cancer.gov/nob/ |
 |
 |
- Last updated refers to the date when our listing for each treatment was last updated.
- ID is a combination of our internal ID and the official ID for the trial, if any.
- Min Karnofsky is a general guide to how well you have to function to use this treatment
|
|
|